Plaintiff wishes to inspect books and records relating to meetings of Clover Health’s Board of Directors (the “Board”) regarding materially false and misleading statements concerning the Company’s business and regulatory compliance.
The Complaint alleges that company representatives including board chairman Chamath Palihapitiya made false and misleading statements about the company’s business and regulatory standing, leading to a federal securities class action in Tennessee and a derivative suit in Delaware. As alleged, “[t]his misconduct has harmed and will continue to harm the company and supplies a credible basis to inspect the circumstances surrounding the dissemination of the statements in question, as well as the board’s controls and reporting systems concerning the public reporting and legal compliance.”
A news article about the case can be viewed here:
To learn more about this matter, contact us today!
